ロード中...
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE
INTRODUCTION: Homocysteine is process-product of methionine demethylation. It has proatherogenic, prothrombotic, prooxidative, proapoptotic, osteoporotic, neurotoxic, neuroinflamatory, and neurodegenerative effects. Hyperhomocysteinemia correlates with C667T MTHFR mutation, decrease of folic acid an...
保存先:
| 出版年: | Mater Sociomed |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AVICENA, d.o.o., Sarajevo
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034996/ https://ncbi.nlm.nih.gov/pubmed/27698607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5455/msm.2016.28.303-306 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|